ARID1A and central nervous system cancer: In our sequencing study cohort, we analyzed the relationship between ARID1A mutations and the prognosis of glioma patients and found that ARID1A mutations were negatively correlated with the prognosis of glioma patients (p = 0.0217) (Figure 2C).